Board of Directors

President
Kathleen Clarence-Smith, MD PhD
Prestwick Pharmaceuticals

President-Elect
James A. Ferrendelli, MD
University of Texas – Houston Medical School

Immediate Past President
Ira Shoulson, MD
University of Rochester

Secretary
John Growdon, MD
Massachusetts General Hospital

Treasurer
Karl Kieburtz, MD
University of Rochester

Directors
Dennis Choi, MD PhD
Merck & Co., Inc.

Mark Corrigan, MD
Sepracor, Inc.

Alan Faden, MD (ex-officio)
Georgetown University Medical Center

Jacqueline French, MD
The Neurological Institute Hospital of the University of Pennsylvania

Christopher Gallen, MD PhD
Wyeth Research

Patricia Grady, PhD
Bethesda, MD

Robert W. Hamill, MD (ex-officio)
University of Vermont

Russell Katz, MD
Rockville, MD

Rosalie Lewis
Dystonia Medical Research Foundation

Donna Masterman, MD
Amgen

William Mobley, MD PhD
Stanford University

Cynthia Rask, MD
Washington, DC

Jeffry Vaught, PhD
Cephalon, Inc.

Daniel Weinberger, MD
Bethesda, MD

Program Committee

Robert W. Hamill, MD (Chair)
University of Vermont

Christopher Gallen, MD PhD (Co-Chair)
Wyeth Research

Marc Walton, MD PhD (Co-Chair)
Food & Drug Administration

Jesse Cedarbaum, MD
Regeneron Pharmaceuticals

Thomas Chase, MD
National Institutes of Health

Kathleen Clarence-Smith, MD PhD
Prestwick Pharmaceuticals

Mark Corrigan, MD
Sepracor, Inc.

Alan I. Faden, MD
Georgetown University Medical Center

Patricia A. Grady, PhD
Bethesda, MD

Robert C. Griggs, MD
University of Rochester

John H. Growdon, MD
Massachusetts General Hospital

Russell Katz, MD
Rockville, MD

Karl Kieburtz, MD
University of Rochester

Rosalie Lewis
Dystonia Medical Research Foundation

Jeffrey Martin, Esq.
Parkinson’s Action Network

Eugene Means, MD
AstraZeneca Pharmaceuticals LP

Ira Shoulson, MD
University of Rochester